Northern Gritstone led the seed extension round, which included participation from ACF Investors, Empirical Ventures, Deeptech Labs, and Hamamatsu Ventures.
"The progress made by the Silveray team since our initial investment in 2023 has been phenomenal. Dan Cathie and his team have the enviable combination of innovation and entrepreneurialism having developed a novel digital x-ray solution with numerous applications which are already disrupting the analogue x-ray market. We are delighted to continue our support of Silveray as it builds its commercial traction, helping the team on its path to success."
The capital injection will accelerate the silicon roadmap for minimally invasive neural implant applications.
"Our semiconductor-based approach is fundamentally reshaping what neural implants can achieve. By offering a customisable, compact solution that integrates seamlessly into medical devices, we’re empowering a new era of neural interfaces that are not only more powerful but also less invasive. This marks a transformative shift in neurological care."
Soulmates Ventures and Deeptech Seed Fund co-led the seed round, which includes £500k from Innovate UK.
"I couldn't be more excited and proud about this next stage in our growth. It is a landmark opportunity, a once in a lifetime moment, to build a transformative product."
The financing round will help the medical technology company advance its epilepsy diagnosis software towards US and Middle Eastern markets.
"We are delighted to have invested in Neuronostics, whose software as a medical device could revolutionise how neurological conditions are diagnosed and treated."
The funding round was led by Extantia Capital and includes £2.4m in non-dilutive capital.
"We want our technology to set a new standard in the waste treatment and energy sectors,by not only optimising waste breakdown but by boosting methane production across the board"
